Porton Pharma Solutions Ltd.

With more than 4,300 employees and 17 operations and commercial offices across the US, EU and China, Porton Pharma Solutions provides global pharmaceutical and biotech companies with innovative, reliable, end-to-end process R&D and GMP manufacturing services spanning small molecules, TIDES, biologics and conjugates (ADCs, AOCs, DACs, PDCs, RDCs and others), as well as advanced therapy medicinal products. Committed to a customer-centric approach, the company has been recognized through industry awards for process innovation, supply chain performance, and compliance with global quality and EHS standards.